CRC “A. M. and A. Migliavacca” Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Italy
Disclosure(s): AbbVie: speaking and teaching fees/ advisory committees and review panels; Aligos: speaking and teaching fees/ advisory committees and review panels; Alnylam: speaking and teaching fees/ advisory committees and review panels; Antios: speaking and teaching fees/ advisory committees and review panels; Arrowhead: speaking and teaching fees/ advisory committees and review panels; Bristol Myers Squibb: speaking and teaching fees/ advisory committees and review panels; Eiger Pharmaceuticals: speaking and teaching fees/ advisory committees and review panels; Gilead Sciences, Inc.: speaking and teaching fees/ advisory committees and review panels; GSK: speaking and teaching fees/ advisory committees and review panels; Janssen: speaking and teaching fees/ advisory committees and review panels; Merck Sharp & Dohme: speaking and teaching fees/ advisory committees and review panels; MYR GmbH: speaking and teaching fees/ advisory committees and review panels; Roche: speaking and teaching fees/ advisory committees and review panels; Spring Bank Pharmaceuticals: speaking and teaching fees/ advisory committees and review panels